When should a pregnant woman with a history of gestational diabetes mellitus (GDM) undergo a Fasting Blood Sugar (FBS) test versus a 75g Oral Glucose Tolerance Test (OGTT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

When to Use FBS vs 75g OGTT in Pregnant Women

For pregnant women with a history of GDM, perform early screening with FBS (or any glucose test) at the first prenatal visit (12-14 weeks), and if negative, mandatory 75g OGTT screening at 24-28 weeks. 1, 2

Early Pregnancy Screening (First Prenatal Visit)

Who Needs Early Screening

Women with the following risk factors should be tested at their first prenatal visit (typically 12-14 weeks):

  • History of previous GDM (4.14 times higher risk) 2
  • BMI ≥30 kg/m² 2
  • Family history of diabetes in first-degree relatives 2
  • High-risk ethnicity (Hispanic, Native American, South or East Asian, African American, Pacific Islander) 2
  • History of delivering macrosomic baby (>4.05 kg) 2
  • History of polycystic ovary syndrome 2

What Test to Use Early

At the first prenatal visit, use FBS or random plasma glucose to detect overt (pre-existing) diabetes, not GDM: 1, 3

  • FBS ≥126 mg/dL = overt diabetes (not GDM) 1
  • Random glucose ≥200 mg/dL with symptoms = overt diabetes 1
  • FBS 92-125 mg/dL = diagnose as GDM 1
  • FBS <92 mg/dL = proceed to 75g OGTT at 24-28 weeks 1

Critical point: Early screening is designed to catch pre-existing undiagnosed type 2 diabetes, not true GDM which develops later in pregnancy. 2 The 75g OGTT is not routinely recommended before 24 weeks even in high-risk women. 1

Standard Screening at 24-28 Weeks (Mandatory for All)

Universal Screening Window

All pregnant women not previously diagnosed with overt diabetes or GDM must undergo screening at 24-28 weeks, including those who tested negative early. 1, 2, 4

Two Screening Approaches

One-Step Approach (75g OGTT):

  • Perform fasting 75g OGTT with measurements at fasting, 1-hour, and 2-hour 1, 4
  • Diagnosis requires only ONE abnormal value: 1, 4, 5
    • Fasting ≥92 mg/dL
    • 1-hour ≥180 mg/dL
    • 2-hour ≥153 mg/dL

Two-Step Approach (50g GCT → 100g OGTT):

  • Initial 50g glucose challenge test (non-fasting) 1, 2
  • If 1-hour glucose ≥140 mg/dL, proceed to fasting 100g OGTT 1
  • Diagnosis requires at least TWO abnormal values: 1, 4
    • Fasting ≥95 mg/dL
    • 1-hour ≥180 mg/dL
    • 2-hour ≥155 mg/dL
    • 3-hour ≥140 mg/dL

The American College of Obstetricians and Gynecologists currently supports the two-step approach, while the American Diabetes Association endorses the one-step approach. 4

Postpartum Follow-Up

Immediate Postpartum Testing

All women diagnosed with GDM must undergo 75g OGTT at 4-12 weeks postpartum using non-pregnancy diagnostic criteria. 1, 4, 5

Why 75g OGTT and not FBS or A1C postpartum?

  • A1C may be falsely lowered by increased red blood cell turnover during pregnancy, blood loss at delivery, or the preceding glucose profile 1
  • The 75g OGTT is more sensitive at detecting glucose intolerance including both prediabetes and diabetes 1

Long-Term Surveillance

Women with history of GDM require lifelong screening for diabetes at least every 1-3 years using any glycemic test (A1C, FBS, or 75g OGTT). 1, 2, 4, 5

Common Pitfalls to Avoid

Not repeating screening at 24-28 weeks in high-risk women who initially test negative leads to delayed diagnosis and treatment. 2 Even with normal early screening, GDM typically develops in the second/third trimester due to increasing insulin resistance.

Using A1C for postpartum diagnosis is unreliable due to pregnancy-related changes in red blood cell turnover. 1 Always use 75g OGTT at 4-12 weeks postpartum.

Performing 75g OGTT before 24 weeks routinely is not recommended even in high-risk women, as there is insufficient evidence of benefit. 1 Use FBS or random glucose for early screening instead.

Failing to screen high-risk women early may miss pre-existing undiagnosed type 2 diabetes, particularly in women with BMI ≥30 kg/m². 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Screening for Gestational Diabetes in Pregnant Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Gestational diabetes mellitus (Update 2023)].

Wiener klinische Wochenschrift, 2023

Guideline

Diagnosing Gestational Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosis and Management of Gestational Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Can gestational diabetes screening be done slightly early at 21 weeks gestational age (GA) if a patient is planning to travel out of the country?
What is the recommended daily caloric intake for a 24-week pregnant woman with gestational diabetes mellitus (GDM), height 160 cm, weight 66 kg, and fasting blood sugar (FBS) of 114 mg/dL?
What is the management plan for a 34-week pregnant woman with gestational diabetes mellitus (GDM), oral glucose tolerance test (OGTT) result of 230 mg/dL, and significant glycosuria (urine sugar 4+), should she be admitted?
What test should be ordered for a 16-week primigravida with a BMI of 35 to screen for gestational diabetes mellitus?
Should I be screened for Gestational Diabetes Mellitus (GDM) at 23 weeks gestation given my family history of Type 2 Diabetes Mellitus (T2DM)?
What are the markers of cholangitis in a patient with a history of liver disease or abdominal surgery?
What is the appropriate dose of hydrocortisone (cortisol) for an 11-year-old patient weighing 35.5kg?
What is the role of the Guy's Stone Score in determining the best treatment approach for an adult patient with a kidney stone?
What is the best course of treatment for a patient with rising Alkaline Phosphatase (ALP) levels and mild hepatopathy, potentially with a history of liver disease or abdominal surgery?
What is the best course of action for a patient with type 2 diabetes (T2D) and hyperglycemia, currently on glipizide (Glipizide) XR 5 mg, with a fasting morning glucose level of hyperglycemia?
What alternative treatment options are available for a patient with diabetes who refuses to take metformin and is currently on glipizide (glyburide) XR 5 mg?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.